Insights

Innovative Therapeutic Focus Gryphon Bio specializes in developing diagnostic-powered therapeutics for brain health, presenting opportunities to collaborate with pharmaceutical companies and healthcare providers seeking novel neurotherapeutic solutions and early diagnosis tools.

Expanding Market Potential With recent initiatives targeting active-duty soldiers, veterans, and pediatric populations suffering from brain-related diseases, there is a strategic opening to engage military health agencies, veterans’ organizations, and pediatric neurology markets.

Rich Scientific Foundation Backed by over 20 years of brain proteomic research and unique discoveries of blood-borne brain molecules, Gryphon Bio offers a strong scientific story to attract partners interested in cutting-edge biomarker and therapeutic development.

Funding & Growth Phase Operating with a modest funding of 750K and generating up to 10 million in revenue, Gryphon Bio is positioned as an early-stage company with growth potential, ideal for investors or early partners looking to support innovative biotech startups.

Technological Edge Utilizing advanced tech stack components like React, Google Analytics, and open graph protocols, Gryphon Bio demonstrates an emphasis on data-driven development and digital engagement, offering opportunities for technological collaborations or platform integrations.

Gryphon Bio Tech Stack

Gryphon Bio uses 8 technology products and services including Google Cloud CDN, Module Federation, Wix eCommerce, and more. Explore Gryphon Bio's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Module Federation
    Development
  • Wix eCommerce
    E-commerce
  • Cart Functionality
    E-commerce
  • Google Cloud
    Infrastructure As A Service
  • Sentry
    Issue Trackers
  • Envoy
    Load Balancers
  • HSTS
    Security

Gryphon Bio's Email Address Formats

Gryphon Bio uses at least 1 format(s):
Gryphon Bio Email FormatsExamplePercentage
First@gryphonbio.comJohn@gryphonbio.com
40%
Last@gryphonbio.comDoe@gryphonbio.com
13%
FirstLast@gryphonbio.comJohnDoe@gryphonbio.com
7%
First@gryphonbio.comJohn@gryphonbio.com
40%

Frequently Asked Questions

Where is Gryphon Bio's headquarters located?

Minus sign iconPlus sign icon
Gryphon Bio's main headquarters is located at 611 Gateway Boulevard Suite 120 Unit 253 South San Francisco, California 94080 United States. The company has employees across 1 continents, including North America.

What is Gryphon Bio's official website and social media links?

Minus sign iconPlus sign icon
Gryphon Bio's official website is gryphonbio.com and has social profiles on LinkedInCrunchbase.

What is Gryphon Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Gryphon Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gryphon Bio have currently?

Minus sign iconPlus sign icon
As of February 2026, Gryphon Bio has approximately 6 employees across 1 continents, including North America. Key team members include Chief Business Officer: D. M.Associate Director Of Clinical Operations And Finance: K. R.Senior Research Scientist: D. J.. Explore Gryphon Bio's employee directory with LeadIQ.

What industry does Gryphon Bio belong to?

Minus sign iconPlus sign icon
Gryphon Bio operates in the Biotechnology Research industry.

What technology does Gryphon Bio use?

Minus sign iconPlus sign icon
Gryphon Bio's tech stack includes Google Cloud CDNModule FederationWix eCommerceCart FunctionalityGoogle CloudSentryEnvoyHSTS.

What is Gryphon Bio's email format?

Minus sign iconPlus sign icon
Gryphon Bio's email format typically follows the pattern of First@gryphonbio.com. Find more Gryphon Bio email formats with LeadIQ.

How much funding has Gryphon Bio raised to date?

Minus sign iconPlus sign icon
As of February 2026, Gryphon Bio has raised $750K in funding. The last funding round occurred on Oct 29, 2023 for $750K.

When was Gryphon Bio founded?

Minus sign iconPlus sign icon
Gryphon Bio was founded in 2018.

Gryphon Bio

Biotechnology ResearchCalifornia, United States2-10 Employees

Gryphon Bio is an early-stage company created to harness our co-founders' discovery of unexpected waves of 1000s of brain molecules in the blood as novel therapeutic targets and temporal blood biomarkers (brain-specific proteins with blood levels that change over time like waves in the ocean). They made these discoveries over more than 20 years of “brain proteomic” research, the large-scale measurement of proteins in the brain. 
Mission: To develop and market the first diagnostic-powered therapeutics for brain health.
Vision: To pioneer diagnostic-powered therapeutics to improve the lives of patients.

Section iconCompany Overview

Headquarters
611 Gateway Boulevard Suite 120 Unit 253 South San Francisco, California 94080 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
2-10

Section iconFunding & Financials

  • $750K

    Gryphon Bio has raised a total of $750K of funding over 11 rounds. Their latest funding round was raised on Oct 29, 2023 in the amount of $750K.

  • $1M$10M

    Gryphon Bio's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $750K

    Gryphon Bio has raised a total of $750K of funding over 11 rounds. Their latest funding round was raised on Oct 29, 2023 in the amount of $750K.

  • $1M$10M

    Gryphon Bio's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.